Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Milestones in the Seasonal Influenza Market’s Growth Trajectory From 2025 To 2034?
The market size of seasonal influenza has seen a swift expansion in the past few years. The increase is projected to go from $8.41 billion in 2024 to about $9.85 billion by 2025, indicating a compound annual growth rate (CAGR) of 17.1%. The significant growth during the historic phase can be credited to factors such as increased incidence of influenza, growing older population, increased occurrence of infectious and chronic diseases, heightened strain due to illness related to influenza, and an increase in respiratory infections.
Anticipations are high for a swift expansion of the seasonal influenza market in the upcoming years. Predictions indicate the growth to reach$18.39 billion by 2029″ moving at a compound annual growth rate (CAGR) of 16.9%. This amplified growth during the forecast period can be connected to increasing demands for oral drug treatments, intensifying research and developmental programs, a rise in vaccination numbers, enhanced healthcare infrastructure, and amplified demand in retail pharmacies. Notable trends for the forecast period involve progress in treatment methods, technological advancement, progress in vaccine technology, mRNA technology, and the introduction of digital health solutions for monitoring and diagnosis.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21285&type=smp
What Are the Core Market Drivers Propelling Growth in the Seasonal Influenza Industry?
The escalating occurrence of respiratory infections is anticipated to spur the expansion of the seasonal influenza market in the future. Respiratory illnesses are infections instigated by viruses or bacteria affecting the respiratory system, including the lungs, airways, throat, and sinuses. The escalated occurrence of such infections is triggered by factors like air pollution, fluctuating weather conditions, compromised immune responses, and easy transmission of viruses in crowded or improperly ventilated areas. Seasonal influenza treatment is instrumental in curtailing or lessening the intensity of these infections in several manners, primarily through its focus on the influenza virus and management of symptoms that can catalyze secondary infections. For example, as per the UK Health Security Agency, a governmental body based in the UK, there was an annual increase of 10.7% in the number of tuberculosis (a respiratory infection effects due to the bacterium called Mycobacterium tuberculosis) cases in England in October 2024, soaring up from 4,380 cases in 2022 to 4,850 cases in 2023. Thus, the surge in respiratory infections is predicted to stimulate the growth of the seasonal influenza market.
How Is the Seasonal Influenza Market Segmented?
The seasonal influenzamarket covered in this report is segmented –
1) By Type: Influenza A Virus; Influenza B Virus; Influenza C Virus; Influenza D Virus
2) By Route Of Administration: Parenteral; Oral; Other Route Of Administrations
3) By Distribution Channel: Hospital; Government and institutional supply; Pharmacy; Online
4) By Treatment: Antiviral; Neuraminidase Inhibitors; Vaccination; Other Treatments
Subsegments:
1) By Influenza A Virus: Subtype H1N1; Subtype H3N2; Other Subtypes
2) By Influenza B Virus: Lineage Victoria; Lineage Yamagata
3) By Influenza C Virus: Seasonal C Virus; Non-seasonal C Virus
4) By Influenza D Virus: Animal-associated Influenza D
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21285&type=smp
Which Regions Are Driving the Next Phase of the Seasonal Influenza Market Growth?
North America was the largest region in the seasonal influenza market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the seasonal influenza market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Seasonal Influenza Industry?
Prominent firms working in the market for seasonal influenza are emphasizing the progression of treatments such as combined vaccines. These vaccines aim to augment immunity by targeting multiple virus strains, increasing the overall efficiency and reducing the necessity for regular vaccinations. Combining vaccines gives protection against various diseases or strains through a single shot, therefore reducing the needed number of vaccinations for immunization. For example, Moderna, Inc., a biotechnology company based in the US, declared promising interim results for Phase 1/2 trials for mRNA-1083, its experimental mixed vaccine against influenza and COVID-19 in October 2023. The design of mRNA-1083 aims to amplify adherence, simplify management, and enhance convenience for individuals and health care structures. It’s currently under evaluation for safety and immunogenicity against standard flu vaccines Fluarix (for ages 50-64) and Fluzone HD (for ages 65-79), and is also being compared with the Spikevax booster.
View the full report here:
https://www.thebusinessresearchcompany.com/report/seasonal-influenza-global-market-report
How Is the Seasonal Influenza Market Defined and What Are Its Core Parameters?
Seasonal influenza, commonly known as the flu, is a contagious respiratory infection caused by influenza viruses that circulate globally, primarily during specific seasons (typically fall and winter in temperate regions). It spreads through respiratory droplets when an infected person coughs, sneezes, or talks. Seasonal influenza leads to widespread illness and can result in serious complications, particularly for vulnerable populations such as the elderly and those with weakened immune systems.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21285
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model